hold up approval for 3 months as they resubmit data
Yee was quoted in IBD news release it is on yahoo news
I'm not an expert on FDA procedures, but I wonder if they would grant a conditional approval based on the phase 2 data while they review the phase 3 data.
Other analysts have also said that the Resonate data would not delay a CLL approval which is expected by the end of February...so which one is it. No way of telling since you won't get it out of PCYC or JNJ.